Oral formulations and lipophilic salts of methylnaltrexone

Details for Australian Patent Application No. 2011224275 (hide)

Owner Wyeth LLC

Inventors Shah, Syed M.; Diorio, Christopher Richard; Ehrnsperger, Eric C.; Meng, Xu; Al Shareffi, Kadum A.; Cohen, Jonathan Marc

Agent Pizzeys

Pub. Number AU-A-2011224275

PCT Pub. Number WO2011/112816

Priority 61/313,018 11.03.10 US

Filing date 10 March 2011

Wipo publication date 15 September 2011

International Classifications

C07D 471/00 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

23 August 2012 PCT application entered the National Phase

  PCT publication WO2011/112816 Priority application(s): WO2011/112816

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011224287-PDE10 inhibitors and related compositions and methods

2011224257-Triggered cargo release from nanoparticle stabilized liposomes